Last Updated: May 23, 2026

Suppliers and packagers for TRIENTINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


TRIENTINE HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Dr Reddys TRIENTINE HYDROCHLORIDE trientine hydrochloride CAPSULE;ORAL 211076 ANDA Dr.Reddys Laboratories Inc 43598-459-01 100 CAPSULE in 1 BOTTLE (43598-459-01) 2019-07-03
Hetero Labs Ltd Iii TRIENTINE HYDROCHLORIDE trientine hydrochloride CAPSULE;ORAL 216356 ANDA Camber Pharmaceuticals, Inc. 31722-683-01 1 BOTTLE in 1 CARTON (31722-683-01) / 100 CAPSULE in 1 BOTTLE 2022-06-23
Msn TRIENTINE HYDROCHLORIDE trientine hydrochloride CAPSULE;ORAL 211134 ANDA Novadoz Pharmaceuticals LLC 72205-008-91 1 BOTTLE in 1 CARTON (72205-008-91) / 100 CAPSULE in 1 BOTTLE 2019-05-22
Navinta Llc TRIENTINE HYDROCHLORIDE trientine hydrochloride CAPSULE;ORAL 211251 ANDA Navinta LLC 68475-200-01 1 BOTTLE in 1 CARTON (68475-200-01) / 100 CAPSULE in 1 BOTTLE 2020-12-05
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for TRIENTINE HYDROCHLORIDE

Last updated: April 23, 2026

Who Supplies Triet(=Trientine) Hydrochloride (Pharmaceutical Grade)?

Which supplier groups provide trientine hydrochloride?

Trientine hydrochloride (often sold as “trientine HCl,” “trientine hydrochloride dihydrate,” or “trientine hydrochloride”) is typically sourced through three channels:

  1. API manufacturers (global bulk producers)
  2. Specialty chemical firms supplying pharma-grade intermediates and final API
  3. Secondary distributors (authorized and general) that repackage and supply commercial quantities

A reliable supplier map depends on (i) whether you need API vs drug substance, (ii) whether you need USP/EP-grade and documentation (CoA/CoC, DMF/CEP), and (iii) target compliance (US FDA, EU CEP, GMP status).

Key supplier sources: common market participants (API and chemical supply)

The most consistent route for sourcing trientine hydrochloride is via established API manufacturers and GMP chemical suppliers that can provide pharma documentation and controlled lot traceability.

Below are supplier types that repeatedly appear in the trientine hydrochloride supply chain (API production and pharma chemical distribution). For many buyers, these firms are the practical starting set for bids because they can provide both technical packages and GMP paperwork.

Supplier type What they sell What buyers typically verify
API manufacturers Trientine hydrochloride as drug substance/API GMP status, CoA, impurity profile, polymorph/grade, lead time
Pharma chemical manufacturers Trientine HCl and related salts (including hydrates) Specification sheet, residual solvents/metals, stability data
Authorized distributors Trientine HCl from branded API sources Traceability to batch/CoA, storage conditions, regulatory documents

Named supplier examples used in commercial sourcing

The following companies are active in chemical/pharma supply networks where trientine hydrochloride is commonly listed or distributed. These names reflect firms that, in practice, sell controlled pharmaceutical chemicals or API-grade materials and are typical bidders for bulk requirements:

  • Hangzhou (or broader) Chinese chemical/API producers that list trientine hydrochloride under pharma-grade SKUs for export (often with DMF-style documentation packs and GMP statements).
  • EU and US-linked API distributors that source from Asian API makers and provide end-user compliance documents (CoA, GMP, labeling).
  • Specialty chemical manufacturers that supply trientine HCl hydrates and provide technical specs for pharma use.

Important: Supplier availability and exact grade (anhydrous vs hydrate), documentation (DMF/CEP), and batch release vary by manufacturer and lot.

How buyers should structure bids to prevent grade and compliance mismatches

For trientine hydrochloride, procurement failures usually come from salt form, hydrate state, and documentation gaps. Bid packages should require:

  • Salt form / hydrate: trientine hydrochloride vs trientine hydrochloride dihydrate
  • Grade target: USP/EP-style specification match (if required)
  • Impurity profile: named/threshold impurities and total impurities limits
  • Residual solvents and metals: per pharma spec
  • Quality documentation: CoA, CoC, GMP statement; and if needed DMF/CEP linkage

Procurement checklist used for API-grade trientine hydrochloride

Use this structure when evaluating quotes:

Verification item Pass criterion buyers set
Specification match Matches agreed internal spec or recognized pharmacopeia spec
Analytical package CoA includes identity, assay, impurities, water content (if hydrate), and residuals
Regulatory readiness GMP letter, batch manufacturing record summary, and traceability to lot
Logistics Storage conditions, shelf-life, lead time, incoterms

Best-fit supplier selection by buyer objective

Buyer objective Supplier channel that fits best
Launching commercial production (API) Direct API manufacturer with consistent GMP batches
Building clinical supply quickly Specialty pharma chemical manufacturer with fast lead times and strong QA documentation
Small-scale formulation / R&D Distributors with flexible packaging and fast shipment, validated traceability

Key Takeaways

  • Trientine hydrochloride sourcing is dominated by API manufacturers and specialty pharma chemical suppliers, with distributors handling volume and packaging.
  • Successful procurement depends on lock-in of salt/hydrate form and pharma documentation (CoA, GMP, impurity and residuals specs).
  • Bid structures that require spec confirmation and lot traceability prevent the most common compliance and grade errors.

FAQs

1) Is trientine hydrochloride supplied as a single “standard” material?

No. It is sold in different forms (commonly hydrated vs non-hydrated grades). Buyers should lock the form in the purchase specification to match formulation and regulatory expectations.

2) What documents matter most for API-grade trientine hydrochloride?

At minimum: CoA/CoC for each lot and a GMP statement. For regulated submissions, buyers also need consistent impurity reporting and traceability.

3) Do distributors sell the same quality as API manufacturers?

They can, but the quality depends on the upstream manufacturer and whether distributors provide full batch documentation tied to the originating API source.

4) How do buyers reduce lead-time and supply risk?

Use a short list of qualified suppliers and require bid commitments for lead time, shelf-life at shipment, and lot-to-lot consistency.

5) What specs should be required beyond assay?

Typically: impurities, water content (if hydrate), residual solvents/metals, and identity confirmation.

References (APA)

[1] FDA. (n.d.). Drug Master Files (DMFs). U.S. Food and Drug Administration. https://www.fda.gov/drugs/development-resources/drug-master-files-dmfs
[2] EMA. (n.d.). Certificates of Suitability (CEPs). European Medicines Agency. https://www.ema.europa.eu/en/human-regulatory/research-development/certificates-suitability
[3] USP. (n.d.). USP Compounding and Standards. United States Pharmacopeia. https://www.uspnf.com/standards

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.